Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
Byers, now 22, had tried all kinds of different methods to lose weight, through exercise and nutrition only, or drugs that suppressed appetite or insulin resistance
No built-in ongoing care
Brain fog is a colloquial term describing a constellation of cognitive symptoms rather than a formal medical diagnosis
This preservative action is what makes bacteriostatic water the standard choice for peptide reconstitution
Over the course of the study, 26% of GLP-1 users stopped taking the medication and about 23% had an interruption of six months or more followed by resuming treatment